Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.
Saved in:
| Title: | Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial. |
|---|---|
| Authors: | Solanich X; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Antolí A; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Rocamora-Blanch G; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Padullés N; Department of Pharmacy, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Fanlo-Maresma M; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Iriarte A; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Mitjavila F; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Capdevila O; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Riera-Mestre A; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain., Bas J; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Vicens-Zygmunt V; Department of Pneumology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Niubó J; Department of Microbiology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Calvo N; Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Bolivar S; Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Rigo-Bonnin R; Department of Clinical Laboratory, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Mensa-Vilaró A; Department of Immunology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain., Arregui L; HUB-ICO-IDIBELL Biobank, Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Tebe C; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Biostatistics, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Videla S; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Hereu P; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Corbella X; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2021 Jun 14; Vol. 8, pp. 691712. Date of Electronic Publication: 2021 Jun 14 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34195214 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Solanich+X%22">Solanich X</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Antolí+A%22">Antolí A</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rocamora-Blanch+G%22">Rocamora-Blanch G</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Padullés+N%22">Padullés N</searchLink>; Department of Pharmacy, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fanlo-Maresma+M%22">Fanlo-Maresma M</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Iriarte+A%22">Iriarte A</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mitjavila+F%22">Mitjavila F</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Capdevila+O%22">Capdevila O</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Riera-Mestre+A%22">Riera-Mestre A</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bas+J%22">Bas J</searchLink>; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Immunology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Vicens-Zygmunt+V%22">Vicens-Zygmunt V</searchLink>; Department of Pneumology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Niubó+J%22">Niubó J</searchLink>; Department of Microbiology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Calvo+N%22">Calvo N</searchLink>; Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bolivar+S%22">Bolivar S</searchLink>; Department of Diagnostic Imaging, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rigo-Bonnin+R%22">Rigo-Bonnin R</searchLink>; Department of Clinical Laboratory, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mensa-Vilaró+A%22">Mensa-Vilaró A</searchLink>; Department of Immunology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Arregui+L%22">Arregui L</searchLink>; HUB-ICO-IDIBELL Biobank, Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tebe+C%22">Tebe C</searchLink>; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Biostatistics, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Videla+S%22">Videla S</searchLink>; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Hereu+P%22">Hereu P</searchLink>; Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Clinical Research and Clinical Trial Unit (UICEC-IDIBELL), Spanish Clinical Research Network, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Corbella+X%22">Corbella X</searchLink>; Department of Internal Medicine, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101648047%22">Frontiers in medicine</searchLink> [Front Med (Lausanne)] 2021 Jun 14; Vol. 8, pp. 691712. <i>Date of Electronic Publication: </i>2021 Jun 14 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101648047 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-858X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296858X%22">2296858X </searchLink><i>NLM ISO Abbreviation: </i>Front Med (Lausanne) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34195214 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fmed.2021.691712 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 691712 Titles: – TitleFull: Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Solanich X – PersonEntity: Name: NameFull: Antolí A – PersonEntity: Name: NameFull: Rocamora-Blanch G – PersonEntity: Name: NameFull: Padullés N – PersonEntity: Name: NameFull: Fanlo-Maresma M – PersonEntity: Name: NameFull: Iriarte A – PersonEntity: Name: NameFull: Mitjavila F – PersonEntity: Name: NameFull: Capdevila O – PersonEntity: Name: NameFull: Riera-Mestre A – PersonEntity: Name: NameFull: Bas J – PersonEntity: Name: NameFull: Vicens-Zygmunt V – PersonEntity: Name: NameFull: Niubó J – PersonEntity: Name: NameFull: Calvo N – PersonEntity: Name: NameFull: Bolivar S – PersonEntity: Name: NameFull: Rigo-Bonnin R – PersonEntity: Name: NameFull: Mensa-Vilaró A – PersonEntity: Name: NameFull: Arregui L – PersonEntity: Name: NameFull: Tebe C – PersonEntity: Name: NameFull: Videla S – PersonEntity: Name: NameFull: Hereu P – PersonEntity: Name: NameFull: Corbella X IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 06 Text: 2021 Jun 14 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 2296-858X Numbering: – Type: volume Value: 8 Titles: – TitleFull: Frontiers in medicine Type: main |
| ResultId | 1 |